This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Kathryn Taylor Linkens: Paving the Way for Innovative Solutions
Introduction:
Kathryn Taylor Linkens, a visionary inventor based in Brookline, MA, continues to inspire the next generation of inventors with her creativity, passion, and dedication to making the world a better place through her innovative solutions.
Latest Patents:
1.Title: 1,2,4-oxadiazole derivatives as liver X receptor agonists
Description: Compounds and pharmaceutical compositions useful for treating meibomian gland dysfunction (MGD) by administering therapeutically effective compounds.
2.Title: 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
Description: Provides a compound for various uses, contributing to advancements in pharmaceutical research.
Career Highlights:
Kathryn Taylor Linkens has made significant contributions to the field of pharmaceuticals while working at Novartis AG. Her dedication to innovation and problem-solving has resulted in patents that address critical medical needs.
Collaborations:
Throughout her career, Kathryn has collaborated with talented professionals like Claire Adcock and Simone Bonazzi. Together, they have worked on cutting-edge projects that push the boundaries of scientific discovery.
Conclusion:
As a pioneering inventor, Kathryn Taylor Linkens's impact extends far beyond her patent portfolio. She serves as a beacon of inspiration for aspiring inventors, demonstrating the power of creativity and determination in driving positive change in the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile